| GO | Name |
| GO:0000122 | negative regulation of transcription by RNA polymerase II |
| GO:0000165 | MAPK cascade |
| GO:0000185 | obsolete activation of MAPKKK activity |
| GO:0000187 | obsolete activation of MAPK activity |
| GO:0000976 | transcription cis-regulatory region binding |
| GO:0001774 | microglial cell activation |
| GO:0001775 | cell activation |
| GO:0001819 | positive regulation of cytokine production |
| GO:0001891 | phagocytic cup |
| GO:0001932 | regulation of protein phosphorylation |
| GO:0001934 | positive regulation of protein phosphorylation |
| GO:0001937 | negative regulation of endothelial cell proliferation |
| GO:0002020 | protease binding |
| GO:0002037 | negative regulation of L-glutamate import across plasma membrane |
| GO:0002269 | leukocyte activation involved in inflammatory response |
| GO:0002439 | chronic inflammatory response to antigenic stimulus |
| GO:0002637 | regulation of immunoglobulin production |
| GO:0002719 | negative regulation of cytokine production involved in immune response |
| GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus |
| GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin |
| GO:0003085 | negative regulation of systemic arterial blood pressure |
| GO:0005125 | cytokine activity |
| GO:0005164 | tumor necrosis factor receptor binding |
| GO:0005615 | extracellular space |
| GO:0005737 | cytoplasm |
| GO:0005886 | plasma membrane |
| GO:0005887 | integral component of plasma membrane |
| GO:0006006 | glucose metabolic process |
| GO:0006357 | regulation of transcription by RNA polymerase II |
| GO:0006915 | apoptotic process |
| GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0006952 | defense response |
| GO:0006954 | inflammatory response |
| GO:0006959 | humoral immune response |
| GO:0007165 | signal transduction |
| GO:0007254 | JNK cascade |
| GO:0007275 | multicellular organism development |
| GO:0008284 | positive regulation of cell population proliferation |
| GO:0008285 | negative regulation of cell population proliferation |
| GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0009615 | response to virus |
| GO:0009887 | animal organ morphogenesis |
| GO:0009897 | external side of plasma membrane |
| GO:0009986 | cell surface |
| GO:0010033 | response to organic substance |
| GO:0010459 | negative regulation of heart rate |
| GO:0010573 | vascular endothelial growth factor production |
| GO:0010628 | positive regulation of gene expression |
| GO:0010629 | negative regulation of gene expression |
| GO:0010693 | negative regulation of alkaline phosphatase activity |
| GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0019722 | calcium-mediated signaling |
| GO:0030141 | secretory granule |
| GO:0030198 | extracellular matrix organization |
| GO:0030316 | osteoclast differentiation |
| GO:0030730 | sequestering of triglyceride |
| GO:0030866 | cortical actin cytoskeleton organization |
| GO:0031334 | positive regulation of protein-containing complex assembly |
| GO:0031622 | positive regulation of fever generation |
| GO:0031642 | negative regulation of myelination |
| GO:0031663 | lipopolysaccharide-mediated signaling pathway |
| GO:0032496 | response to lipopolysaccharide |
| GO:0032715 | negative regulation of interleukin-6 production |
| GO:0032722 | positive regulation of chemokine production |
| GO:0032724 | positive regulation of fractalkine production |
| GO:0032729 | positive regulation of interferon-gamma production |
| GO:0032731 | positive regulation of interleukin-1 beta production |
| GO:0032741 | positive regulation of interleukin-18 production |
| GO:0032755 | positive regulation of interleukin-6 production |
| GO:0032757 | positive regulation of interleukin-8 production |
| GO:0033138 | positive regulation of peptidyl-serine phosphorylation |
| GO:0033209 | tumor necrosis factor-mediated signaling pathway |
| GO:0034116 | positive regulation of heterotypic cell-cell adhesion |
| GO:0034138 | toll-like receptor 3 signaling pathway |
| GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity |
| GO:0042127 | regulation of cell population proliferation |
| GO:0042311 | vasodilation |
| GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein |
| GO:0042742 | defense response to bacterium |
| GO:0042802 | identical protein binding |
| GO:0043025 | neuronal cell body |
| GO:0043065 | positive regulation of apoptotic process |
| GO:0043066 | negative regulation of apoptotic process |
| GO:0043068 | positive regulation of programmed cell death |
| GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0043242 | negative regulation of protein-containing complex disassembly |
| GO:0043243 | positive regulation of protein-containing complex disassembly |
| GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0043406 | positive regulation of MAP kinase activity |
| GO:0043491 | protein kinase B signaling |
| GO:0043507 | positive regulation of JUN kinase activity |
| GO:0043525 | positive regulation of neuron apoptotic process |
| GO:0043537 | negative regulation of blood vessel endothelial cell migration |
| GO:0045071 | negative regulation of viral genome replication |
| GO:0045121 | membrane raft |
| GO:0045123 | cellular extravasation |
| GO:0045429 | positive regulation of nitric oxide biosynthetic process |
| GO:0045599 | negative regulation of fat cell differentiation |
| GO:0045662 | negative regulation of myoblast differentiation |
| GO:0045668 | negative regulation of osteoblast differentiation |
| GO:0045670 | regulation of osteoclast differentiation |
| GO:0045672 | positive regulation of osteoclast differentiation |
| GO:0045732 | positive regulation of protein catabolic process |
| GO:0045760 | positive regulation of action potential |
| GO:0045785 | positive regulation of cell adhesion |
| GO:0045840 | positive regulation of mitotic nuclear division |
| GO:0045860 | positive regulation of protein kinase activity |
| GO:0045892 | negative regulation of transcription, DNA-templated |
| GO:0045893 | positive regulation of transcription, DNA-templated |
| GO:0045930 | negative regulation of mitotic cell cycle |
| GO:0045944 | positive regulation of transcription by RNA polymerase II |
| GO:0045994 | positive regulation of translational initiation by iron |
| GO:0046325 | negative regulation of glucose import |
| GO:0046330 | positive regulation of JNK cascade |
| GO:0046427 | positive regulation of receptor signaling pathway via JAK-STAT |
| GO:0048566 | embryonic digestive tract development |
| GO:0048661 | positive regulation of smooth muscle cell proliferation |
| GO:0050708 | regulation of protein secretion |
| GO:0050727 | regulation of inflammatory response |
| GO:0050729 | positive regulation of inflammatory response |
| GO:0050766 | positive regulation of phagocytosis |
| GO:0050796 | regulation of insulin secretion |
| GO:0050806 | positive regulation of synaptic transmission |
| GO:0050807 | regulation of synapse organization |
| GO:0050830 | defense response to Gram-positive bacterium |
| GO:0050900 | leukocyte migration |
| GO:0050901 | leukocyte tethering or rolling |
| GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain |
| GO:0050995 | negative regulation of lipid catabolic process |
| GO:0051000 | positive regulation of nitric-oxide synthase activity |
| GO:0051044 | positive regulation of membrane protein ectodomain proteolysis |
| GO:0051091 | positive regulation of DNA-binding transcription factor activity |
| GO:0051092 | positive regulation of NF-kappaB transcription factor activity |
| GO:0051173 | positive regulation of nitrogen compound metabolic process |
| GO:0051222 | positive regulation of protein transport |
| GO:0051384 | response to glucocorticoid |
| GO:0051798 | positive regulation of hair follicle development |
| GO:0051897 | positive regulation of protein kinase B signaling |
| GO:0055037 | recycling endosome |
| GO:0060252 | positive regulation of glial cell proliferation |
| GO:0060557 | positive regulation of vitamin D biosynthetic process |
| GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity |
| GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis |
| GO:0060693 | regulation of branching involved in salivary gland morphogenesis |
| GO:0061044 | negative regulation of vascular wound healing |
| GO:0061048 | negative regulation of branching involved in lung morphogenesis |
| GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade |
| GO:0071222 | cellular response to lipopolysaccharide |
| GO:0071230 | cellular response to amino acid stimulus |
| GO:0071316 | cellular response to nicotine |
| GO:0071407 | cellular response to organic cyclic compound |
| GO:0071803 | positive regulation of podosome assembly |
| GO:0072577 | endothelial cell apoptotic process |
| GO:0072659 | protein localization to plasma membrane |
| GO:0090324 | negative regulation of oxidative phosphorylation |
| GO:0097190 | apoptotic signaling pathway |
| GO:0097191 | extrinsic apoptotic signaling pathway |
| GO:0097527 | necroptotic signaling pathway |
| GO:0120190 | negative regulation of bile acid secretion |
| GO:0150129 | positive regulation of interleukin-33 production |
| GO:1900017 | positive regulation of cytokine production involved in inflammatory response |
| GO:1900222 | negative regulation of amyloid-beta clearance |
| GO:1901224 | positive regulation of NIK/NF-kappaB signaling |
| GO:1901647 | positive regulation of synoviocyte proliferation |
| GO:1901671 | positive regulation of superoxide dismutase activity |
| GO:1902004 | positive regulation of amyloid-beta formation |
| GO:1902565 | positive regulation of neutrophil activation |
| GO:1902895 | positive regulation of pri-miRNA transcription by RNA polymerase II |
| GO:1903078 | positive regulation of protein localization to plasma membrane |
| GO:1903140 | regulation of establishment of endothelial barrier |
| GO:1903223 | positive regulation of oxidative stress-induced neuron death |
| GO:1903347 | negative regulation of bicellular tight junction assembly |
| GO:1903721 | positive regulation of I-kappaB phosphorylation |
| GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation |
| GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell |
| GO:1904999 | positive regulation of leukocyte adhesion to arterial endothelial cell |
| GO:2000010 | positive regulation of protein localization to cell surface |
| GO:2000272 | negative regulation of signaling receptor activity |
| GO:2000334 | positive regulation of blood microparticle formation |
| GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production |
| GO:2000347 | positive regulation of hepatocyte proliferation |
| GO:2000351 | regulation of endothelial cell apoptotic process |
| GO:2000377 | regulation of reactive oxygen species metabolic process |
| GO:2000573 | positive regulation of DNA biosynthetic process |
| GO:2001234 | negative regulation of apoptotic signaling pathway |
| GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway |
| GO:2001240 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:2001272 | positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis |